@article {Nakhoul613, author = {Georges Nakhoul and James F. Simon}, title = {Anemia of chronic kidney disease: Treat it, but not too aggressively}, volume = {83}, number = {8}, pages = {613--624}, year = {2016}, doi = {10.3949/ccjm.83a.15065}, publisher = {Cleveland Clinic Journal of Medicine}, abstract = {Anemia of renal disease is common and is associated with significant morbidity and death. It is mainly caused by a decrease in erythropoietin production in the kidneys and can be partially corrected with erythropoiesis-stimulating agents (ESAs). However, randomized controlled trials have shown that using ESAs to target normal hemoglobin levels can be harmful, and have called into question any benefits of ESA treatment other than avoidance of transfusions.}, issn = {0891-1150}, URL = {https://www.ccjm.org/content/83/8/613}, eprint = {https://www.ccjm.org/content/83/8/613.full.pdf}, journal = {Cleveland Clinic Journal of Medicine} }